MedTrace Logo

Excessive Warfarin Anticoagulation - Causes and Consequences

NCT02761941 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 25000

Last updated 2016-05-05

No results posted yet for this study

Summary

The aim of this study is to investigate the clinical significance of high INR (International Normalized Ratio) values (\>9) in VKA (vitamin K antagonist) treated patients with atrial fibrillation. The clinical characteristics of these patients will be studied as well as the clinical presentation. Factors influencing on high INR values will be recorded and the aim is to seek out patients who have elevated risk of bleeding complications.

Conditions

  • Anticoagulation

Sponsors & Collaborators

  • University of Turku

    lead OTHER

Principal Investigators

  • Juhani Airaksinen, Professor · Turku University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02761941 on ClinicalTrials.gov